Instituto Hermes Pardini SA
BOVESPA:PARD3
Instituto Hermes Pardini SA
BOVESPA:PARD3
Price:
20.25
BRL
Market Cap:
R$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Instituto Hermes Pardini SA
BOVESPA:PARD3
|
BR |
|
A
|
Aegean Airlines SA
ATHEX:AEGN
|
GR |
|
I
|
Imagis Co Ltd
KOSDAQ:115610
|
KR |
|
J
|
Jay Bharat Maruti Ltd
NSE:JAYBARMARU
|
IN |
|
D
|
DB Energy SA
WSE:DBE
|
PL |
|
M
|
Mr Blue Corp
KOSDAQ:207760
|
KR |
|
Wal Mart de Mexico SAB de CV
OTC:WMMVF
|
MX |
|
CSSC Offshore & Marine Engineering Group Co Ltd
SSE:600685
|
CN |
|
Softwareone Holding AG
OTC:SWONF
|
CH |
|
Leonardo SpA
MIL:LDO
|
IT |
|
Ad-Sol Nissin Corp
TSE:3837
|
JP |
|
E
|
Ekachai Medical Care PCL
SET:EKH
|
TH |
|
IndoStar Capital Finance Ltd
NSE:INDOSTAR
|
IN |
|
I
|
Innospace Co Ltd
KOSDAQ:462350
|
KR |
|
Samwha Electronics Co Ltd
KRX:011230
|
KR |
|
With us Corp
TSE:9696
|
JP |
|
E
|
Empower India Ltd
BSE:504351
|
IN |
Relative Value
There is not enough data to reliably calculate the relative value of PARD3.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PARD3
Relative Value
Base Case
Not Available
Multiples Across Competitors
PARD3 Competitors Multiples
Instituto Hermes Pardini SA Competitors
Instituto Hermes Pardini SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Instituto Hermes Pardini SA
BOVESPA:PARD3
|
2.6B BRL | 1.2 | 15 | 6.2 | 9.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
92.5B USD | 0.2 | 51.6 | 13.5 | 13.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 13.1 | 7.7 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
70B USD | 0.3 | 11.9 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.9B EUR | 1.1 | 19.9 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.3B EUR | 1.1 | 22.8 | 8.8 | 16.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25.1 | 12 | 17.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 2 | 22 | 11.9 | 16 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.6B EUR | 0.5 | 10.9 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | 11.1 | -26.2 | -28.7 | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14.1 | 7.2 | 9.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
